Bioinductive Patch for Full-Thickness Rotator Cuff Tears
NCT ID: NCT05439850
Last Updated: 2025-02-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE4
78 participants
INTERVENTIONAL
2022-08-16
2027-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Study of Augment Rotator Cuff for Surgical Treatment of Full Thickness Rotator Cuff Tears
NCT01256242
BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears
NCT05997381
REGENETEN™ Bioinductive Implant System in Full-thickness Tears
NCT04450342
Efficacy of an Amniotic Fluid Derived Allograft, (FlōGraft®) in Rotator Cuff Repairs: A Prospective Study
NCT03379324
Novel Treatment for Rotator Cuff Tears
NCT05590494
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
Surgical treatment alone, consisting of arthroscopic rotator cuff repair. Ultrasound postoperatively at 1 year.
arthroscopic rotator cuff repair
This procedure is the standard of care for rotator cuff tears who fail conservative treatment options.
Ultrasound Imaging
An ultrasound will be performed on each patient one year postoperatively.
Study Group
Identical surgical treatment as control group plus bio-inductive patch implant. Ultrasound postoperatively at 1 year.
arthroscopic rotator cuff repair
This procedure is the standard of care for rotator cuff tears who fail conservative treatment options.
Bioinductive implant
A bioinductive implant that is designed to promote healing of the torn rotator cuff tendon after surgery.
Ultrasound Imaging
An ultrasound will be performed on each patient one year postoperatively.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
arthroscopic rotator cuff repair
This procedure is the standard of care for rotator cuff tears who fail conservative treatment options.
Bioinductive implant
A bioinductive implant that is designed to promote healing of the torn rotator cuff tendon after surgery.
Ultrasound Imaging
An ultrasound will be performed on each patient one year postoperatively.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Full-thickness medium (1-3 cm), large (3-5 cm), and massive (\>5 cm) rotator cuff tears involving the supraspinatus and/or infraspinatus tendons demonstrated on magnetic resonance or ultrasound imaging.
* Chronic, degenerative rotator cuff tears.
* Ability to read and understand English.
* Age ≥18 years
* Patient failed ≥6 weeks of conservative treatment, which included structured, in-person physical therapy or documented home therapy
Exclusion Criteria
* Prior surgery of affected shoulder (except diagnostic arthroscopy)
* Partial-thickness rotator cuff tears
* Small (\<1 cm) rotator cuff tears
* Rotator cuff tears involving the subscapularis tendon
* Acute and traumatic rotator cuff tears
* Active infection
* Cancer
* Autoimmune and rheumatologic disorders, including rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Henry Ford Health System
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stephanie Muh, MD
Deputy Service Chief, Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephanie J Muh, MC
Role: PRINCIPAL_INVESTIGATOR
Henry Ford Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Henry Ford Health
Detroit, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Stephanie J Muh, MD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15702
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.